The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug

The pharmaceutical industry is no stranger to fierce competition and patent disputes. In recent years, one drug has taken the market by storm and achieved blockbuster status. Ozempic, a medication for the treatment of type 2 diabetes, has garnered significant attention and popularity. However, its manufacturer, Novo Nordisk, finds itself⁤ in a ​battle to ⁣protect… Continue reading The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug

Makers of Ozempic and Mounjaro Sued Over Allegedly ‘Downplaying’ Severe Side Effects

On June 2nd, a group of plaintiffs filed a lawsuit against the makers of two popular diabetes drugs, Ozempic and Mounjaro, claiming that the companies deliberately downplayed the significant side effects of the drugs. The plaintiffs allege that the manufacturers, Merck & Co. and Novo Nordisk, misrepresented the potential for serious side effects in order… Continue reading Makers of Ozempic and Mounjaro Sued Over Allegedly ‘Downplaying’ Severe Side Effects

Exit mobile version